Literature DB >> 6313141

Sustained improvement in tardive dyskinesia with diazepam: indirect evidence for corticolimbic involvement.

M M Singh, R E Becker, R K Pitman, H A Nasrallah, H Lal.   

Abstract

A rater-bind, ABA's design study of 21 cases indicates that diazepam significantly improves tardive dyskinesia and that some of the improvement persists for an extended period after diazepam is withdrawn. Since benzodiazepine receptors and sites of action seem to be mainly in the neocortex (especially frontal), limbic cortex, and deep limbs nuclei, and these structures provide most of the input into the nigrostriatopallidal system that probably regulates its role in voluntary movement, it may be suggested that impaired corticolimbic control of basal ganglia may be a factor in the pathogenesis of tardive dyskinesia.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6313141     DOI: 10.1016/0361-9230(83)90188-0

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  5 in total

1.  Oro-facial dyskinesia and the sub-commissural part of the globus pallidus in the cat: role of acetylcholine and its interaction with GABA.

Authors:  W P Spooren; E Cuypers; A R Cools
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 2.  VMAT2 Inhibitors in Neuropsychiatric Disorders.

Authors:  Arjun Tarakad; Joohi Jimenez-Shahed
Journal:  CNS Drugs       Date:  2018-12       Impact factor: 5.749

Review 3.  Benzodiazepines for antipsychotic-induced tardive dyskinesia.

Authors:  Hanna Bergman; Paranthaman S Bhoopathi; Karla Soares-Weiser
Journal:  Cochrane Database Syst Rev       Date:  2018-01-20

Review 4.  Treatment of neurolept-induced tardive dyskinesia.

Authors:  Stacey K Jankelowitz
Journal:  Neuropsychiatr Dis Treat       Date:  2013-09-16       Impact factor: 2.570

5.  MSBIS: A Multi-Step Biomedical Informatics Screening Approach for Identifying Medications that Mitigate the Risks of Metoclopramide-Induced Tardive Dyskinesia.

Authors:  Dong Xu; Alexandrea G Ham; Rickey D Tivis; Matthew L Caylor; Aoxiang Tao; Steve T Flynn; Peter J Economen; Hung K Dang; Royal W Johnson; Vaughn L Culbertson
Journal:  EBioMedicine       Date:  2017-11-22       Impact factor: 8.143

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.